ARCELIS Trademark

Trademark Overview

On Monday, May 7, 2007, a trademark application was filed for ARCELIS with the United States Patent and Trademark Office. The USPTO has given the ARCELIS trademark a serial number of 77174310. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 13, 2022. This trademark is owned by Argos Therapeutics, Inc.. The ARCELIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development for others in the field of human diseases and vaccines, namely, research and development of cell preparations, cellular vaccines, and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy
arcelis

General Information

Serial Number77174310
Word MarkARCELIS
Filing DateMonday, May 7, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 13, 2022
Registration Number4841570
Registration DateTuesday, October 27, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2011

Trademark Statements

Goods and ServicesResearch and development for others in the field of human diseases and vaccines, namely, research and development of cell preparations, cellular vaccines, and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 13, 2022
Primary Code042
First Use Anywhere DateMonday, December 15, 2014
First Use In Commerce DateMonday, December 15, 2014

Trademark Owner History

Party NameArgos Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27704
Party NameArgos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27704
Party NameArgos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27704

Trademark Events

Event DateEvent Description
Friday, May 13, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, October 27, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 27, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, September 23, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 19, 2015NON-FINAL ACTION E-MAILED
Thursday, March 19, 2015SU - NON-FINAL ACTION - WRITTEN
Sunday, March 1, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, January 16, 2015USE AMENDMENT FILED
Friday, January 16, 2015TEAS STATEMENT OF USE RECEIVED
Friday, October 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 9, 2014SOU EXTENSION 5 GRANTED
Thursday, October 2, 2014SOU EXTENSION 5 FILED
Thursday, October 2, 2014TEAS EXTENSION RECEIVED
Tuesday, May 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 5, 2014SOU EXTENSION 4 GRANTED
Thursday, April 24, 2014SOU EXTENSION 4 FILED
Thursday, April 24, 2014TEAS EXTENSION RECEIVED
Thursday, October 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2013CORRECTED NOA E-MAILED
Wednesday, October 9, 2013SOU EXTENSION 3 GRANTED
Wednesday, October 2, 2013SOU EXTENSION 3 FILED
Wednesday, October 9, 2013DIVISIONAL PROCESSING COMPLETE
Wednesday, October 2, 2013DIVISIONAL REQUEST RECEIVED
Wednesday, October 2, 2013TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Friday, May 10, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, May 8, 2013SOU EXTENSION 2 GRANTED
Monday, April 15, 2013SOU EXTENSION 2 FILED
Friday, May 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 15, 2013TEAS EXTENSION RECEIVED
Saturday, October 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, October 18, 2012SOU EXTENSION 1 GRANTED
Thursday, October 18, 2012SOU EXTENSION 1 FILED
Thursday, October 18, 2012TEAS EXTENSION RECEIVED
Tuesday, April 24, 2012NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 12, 2012TTAB RELEASE CASE TO TRADEMARKS
Monday, March 12, 2012OPPOSITION TERMINATED NO. 999999
Monday, March 12, 2012OPPOSITION DISMISSED NO. 999999
Monday, February 27, 2012PAPER RECEIVED
Wednesday, October 12, 2011OPPOSITION INSTITUTED NO. 999999
Monday, April 25, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 12, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2011NOTICE OF PUBLICATION
Tuesday, March 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 8, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 1, 2011SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, August 27, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 27, 2010ASSIGNED TO LIE
Friday, February 26, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 23, 2010ASSIGNED TO LIE
Sunday, August 23, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 23, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 21, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 21, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 21, 2008ASSIGNED TO LIE
Tuesday, August 21, 2007LETTER OF SUSPENSION MAILED
Monday, August 20, 2007SUSPENSION LETTER WRITTEN
Monday, August 20, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 20, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 20, 2007ASSIGNED TO EXAMINER
Thursday, May 10, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

arcelis vaccines research cellular diseases cell development cancer infectious autologous immunotherapy